Over the past year-and-a-half, more than 100 people have received new disease-modifying drugs for Alzheimer’s disease at the Indiana University Health Neuroscience Center in downtown Indianapolis, and that number grows weekly. Not only are the patients among the first people in the country to receive the treatment, but they’re contributing to the work of researchers from the IU School of Medicine who are actively studying the long-term effects of the drugs.
April 24, 2025
IU School of Medicine dedicates Medical Education and Research Building in new Indy Health District
On April 22, 2025, IU held a dedication ceremony for the School of Medicine’s new Medical Education and Research Building that will open this summer right next to IU Health's new hospital in the Indy Health District.April 22, 2025
Parkinson's researchers discover 'tip of the ICE-berg' on quest for a cure
Parkinson's researcher Malú Tansey brings cell-level science to IU’s already strong clinical research program. Her lab engages in "paradigm-shifting work" studying inflammation and immune response in Parkinson's.March 31, 2025
Symposium invites community, scientific leaders to better understand brain health, neurodegeneration
The IU School of Medicine will highlight its robust neuroscience research program April 13 and 14 at the inaugural Center for Neurodegenerative Disorders Symposium.
March 26, 2025
Researchers identify potential link between retinal changes, Alzheimer’s disease
A team of scientists at the Indiana University School of Medicine has identified that an eye condition affecting the retina, the light-sensing tissue in the back of the eye, may serve as an early indicator for Alzheimer's disease.February 26, 2025
A new multi-institutional project, funded up to $46 million by the Advanced Research Projects Agency for Health (ARPA-H), aims to develop treatments to restore vision through whole eye transplantation. The award supports the Total Human Eye-allotransplantation Innovation Advancement (THEIA) project led by the University of Colorado Anschutz Medical Campus. Indiana University School of Medicine is one of eight institutions contributing to this groundbreaking research.
December 16, 2024
Malú Tansey, PhD and her team of researchers like to think “outside the brain.” Her lab investigates the role of inflammation and immune system responses on brain health and the development of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and frontal temporal dementia, with a specific focus on the gut-brain connection.
October 21, 2024
Newly discovered genetic marker could pave the way for future Alzheimer's disease therapeutics
Researchers have identified a new genetic marker that could play a role in the development of Alzheimer's disease and pave the way for novel therapeutic targets and diagnostic tools for the disease.
October 08, 2024